| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Dec 8, 2021 | RDIF and Sovcombank arranged a visit of a Russian business mission to Argentina | Moscow, December 8, 2021 – The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) and the Fund’s portfolio company, Sovcombank, have arranged a business mission to Argentina. Representatives of major Russian companies are... |
| Dec 7, 2021 | Recommendations of EMA and ongoing combo studies support mix&match approach pioneered by Sputnik team to fight COVID | Moscow, December 7, 2021 – The European Medicines Agency (EMA) today announced the heterologous vaccination (mix&match) approach (pioneered by the Russian Sputnik vaccine) can be used for both initial vaccination courses and boosters pr... |
| Dec 6, 2021 | The one-shot Sputnik Light vaccine authorized in Argentina as a standalone vaccine and a booster shot | Moscow, December 6, 2021 – The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) today announced the Russian one-shot Sputnik Light vaccine against coronavirus has been approved by the Ministry of Health of Argentina as ... |
| Dec 6, 2021 | RDIF ready to provide the one-shot Sputnik Light vaccine and Sputnik M vaccine (for adolescents) as it develops strategic cooperation with partners in India to fight COVID | Moscow, December 6, 2021 – Partnership between Russia and India in the fight against COVID has already demonstrated significant results, and the Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) strives to expand it thro... |
| Dec 5, 2021 | Saudi Arabia has joined more than 100 countries accepting visitors vaccinated with Sputnik V following extensive work between Ministry of Health of Saudi Arabia and RDIF, supported by the Ministry of Investments of Saudi Arabia | Moscow, December 5, 2021 – The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) announces that the Kingdom of Saudi Arabia has granted approval for entry of individuals vaccinated with the Russian Sputnik V vaccine star... |
| Dec 1, 2021 | RDIF signs agreements with partners in Vietnam to expand production of the Russian Sputnik V vaccine | Moscow, December 1, 2021 – The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) announces expansion of cooperation with partners in Vietnam aimed at production of the Russian Sputnik V vaccine against coronavirus and si... |
| Nov 30, 2021 | The one-shot Sputnik Light vaccine authorized in UAE as a universal booster shot | Moscow, November 30, 2021 – The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) today announced the Russian single-component Sputnik Light vaccine against coronavirus has been approved by the Ministry of Health and Pre... |
| Nov 29, 2021 | Statement of RDIF and the Gamaleya Institute on Omicron variant of COVID | Moscow, November 29, 2021 – The Russian Sputnik V and Sputnik Light vaccines have proven to be highly effective against all variants of SARC-Cov-2 known to date. This has been demonstrated by an article published in Vaccines medical journal... |
| Nov 26, 2021 | RDIF and RCIF participate in the meeting of Intergovernmental Russian-Chinese Commission for Investment Cooperation | Moscow, November 26, 2021 – Representatives of the Russian Direct Investment Fund (RDIF), Russia’s sovereign wealth fund, and the Russia-China Investment Fund (RCIF) have participated in the eighth meeting of the Intergovernmental Russian-C... |
| Nov 25, 2021 | A unique comparative study of five vaccines in EU member Hungary on 3.7 million people shows Sputnik V is the best vaccine to protect against mortality from COVID with 98% efficacy and 85.7% efficacy against infection | Moscow, November 25, 2021 – A unique independent nationwide observational study in EU member state Hungary estimating and directly comparing efficacy of five vaccines against COVID has demonstrated that the Russian Sputnik V vaccine has the... |
| Nov 24, 2021 | Sputnik V shows 80% long-term efficacy against COVID in San Marino from 6th through 8th month after administering the second dose | Moscow, November 24, 2021 – The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) announces the real-world data of the Ministry of Health of the Republic of San Marino on the Russian Sputnik V vaccine demonstrating it is... |
| Nov 24, 2021 | Sputnik V shows 80% long-term efficacy against COVID in San Marino from 6th through 8th month after administering the second dose | Moscow, November 24, 2021 – The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) today announced new positive real-world data of the Ministry of Health of the Republic of San Marino on efficacy of the Russian Sputnik V ... |
| Nov 23, 2021 | The one-shot Sputnik Light vaccine authorized in San Marino | Sputnik Light has also been approved in San Marino as a booster shot for all vaccines administered in the country |
| Nov 23, 2021 | Laos becomes the 20th country to authorize the one-shot Sputnik Light vaccine | Moscow, November 23, 2021 – The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) today announced the Russian single-component Sputnik Light vaccine against coronavirus has been approved in Lao People’s Democratic Republ... |
| Nov 17, 2021 | A study in Belarus on Sputnik V shows high safety profile and 96.3% efficacy against COVID after vaccination of over 1.2 million people | Moscow, November 17, 2021 – The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) announces the Russian Sputnik V coronavirus vaccine has demonstrated 96.3% efficacy and high safety profile based on new study of vaccinat... |
| Nov 12, 2021 | Russian and Chinese business leaders discuss cooperation and new joint investments | Moscow, November 12, 2021 – Representatives of leading Russian and Chinese companies discussed the development of cooperation in bilateral trade and investments between Russia and China at today’s annual meeting of the Russian-Chinese Busin... |
| Nov 3, 2021 | A study published in The Lancet confirms the one-shot Sputnik Light vaccine has a high safety profile and induces a strong humoral and cellular immune response both in the seronegative and seropositive groups | Moscow, November 3, 2021 – The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) announces a new publication by the Gamaleya Center in The Lancet, one of the world's most respected medical journals, showing the one-shot ... |
| Nov 1, 2021 | A study in the city of Buenos Aires confirms high efficacy of the Sputnik V in protecting individuals aged 60+ | Moscow, November 1, 2021 – The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) announces the results of a comprehensive real world study by the Ministry of Health of the City of Buenos Aires (Argentina) confirming high... |
| Oct 31, 2021 | Sputnik V and Sputnik Light vaccines authorized in Cambodia | Moscow, October 31, 2021 – The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) announces the approval of the Russian Sputnik V and Sputnik Light vaccines against coronavirus in Cambodia. |
| Oct 29, 2021 | Individuals vaccinated with Sputnik V in Argentina are now eligible to enter EU | Sputnik V has helped reduce infections with COVID by more than 30 times in Argentina |
| Oct 28, 2021 | Israel joins 100 other countries in accepting the Sputnik V vaccine | Moscow, October 28, 2021 – The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) announces that Israeli authorities have granted approval for entry of individuals vaccinated with the Sputnik V vaccine. To date, a total o... |
| Oct 26, 2021 | GL Rapha becomes the first international partner of RDIF to obtain Russian GMP Certificate for Sputnik family vaccine production in Korea | Moscow, October 26, 2021 – The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund), and GL Rapha, one of the leading South Korean bio-tech companies (through the subsidiary company Hankook Korus Pharm Co., Ltd) announce th... |
| Oct 21, 2021 | Approval of mixing and matching of COVID booster shots by FDA is yet another confirmation of efficacy of vaccine cocktail approach pioneered by the Russian Sputnik V vaccine | Moscow, October 21, 2021 – Following the decision by the U.S. Food and Drug Administration allowing individuals to receive booster shots that are different from their first COVID-19 vaccine doses, the Russian Direct Investment Fund (RDIF, R... |
| Oct 14, 2021 | Interim results of a pioneering combination study in Argentina with more than 1,000 participants confirm the one-shot Sputnik Light vaccine (the first component of the Sputnik V vaccine) is an effective universal booster for vaccines produced by Astrazeneca, Sinopharm, Moderna and Cansino induci ... | Moscow, October 14, 2021 – The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) announces the interim results of the study in Argentina on heterogeneous regimens combining Sputnik Light (the first component of the Russi... |
| Oct 13, 2021 | One-shot Sputnik Light vaccine (first component of the Sputnik V vaccine) demonstrates 70% efficacy against infection with the Delta variant during the first three months after vaccination, Gamaleya Center analysis shows | Moscow, October 13, 2021 – The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) and Gamaleya National Research Center of Epidemiology and Microbiology today announced the results of an efficacy analysis of the one-shot ... |
| Oct 7, 2021 | RDIF is inviting international scientists and scientific institutions to cooperate on research of real-world data/real-world evidence (RWD/RWE) on safety and efficacy of Sputnik V, Sputnik Light and other vaccines against coronavirus | Moscow, October 7, 2021 – The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) is inviting independent international researchers and scientific institutions to cooperate on real-world studies of safety and efficacy of c... |
| Oct 6, 2021 | The single-component Sputnik Light vaccine authorized in UAE | Sputnik Light has also been approved in UAE as a booster shot |
| Sep 27, 2021 | A clinical study of the combination of AstraZeneca and Sputnik Light vaccines in Azerbaijan shows strong neutralizing antibodies growth in the majority of participants | Moscow, September 27, 2021 – The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund), AstraZeneca and R-Pharm announce preliminary virus neutralizing activity results of combined use of the AstraZeneca vaccine (developed j... |
| Sep 24, 2021 | The single-component Sputnik Light vaccine authorized in Egypt | Moscow, September 24, 2021 – The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) today announced the Russian single-component Sputnik Light vaccine against coronavirus has been approved by the Egyptian Drug Authority (... |
| Sep 15, 2021 | Sputnik V demonstrates 97.2% efficacy and high safety profile against COVID during the vaccination campaign in Belarus | Moscow, September 15, 2021 – The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) announces the real world data of the Ministry of Health of the Republic of Belarus on the Russian Sputnik V coronavirus vaccine confirmin... |
| Sep 15, 2021 | The single-component Sputnik Light vaccine authorized in Iran | Moscow, September 15, 2021 – The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) today announced the Russian single-component Sputnik Light vaccine against coronavirus has been approved by the Ministry of Health of the... |
| Sep 13, 2021 | Study on Sputnik Light (first component of Sputnik V) vaccine’s efficacy among the elderly in Argentina published in EClinicalMedicine journal | ClinicalMedicine is an open access peer-reviewed clinical journal published by The Lancet, one of the world's most respected medical journals |
| Sep 6, 2021 | The single-component Sputnik Light vaccine authorized in Armenia | Moscow, September 6, 2021 – The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) today announced the Russian single-component Sputnik Light vaccine against coronavirus has been approved by the Ministry of Health of the ... |
| Sep 2, 2021 | Sputnik V demonstrates 94.8% efficacy against COVID during the vaccination campaign in San Marino | Moscow, September 2, 2021 – The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) announces the real world data of the Ministry of Health of San Marino on the Russian Sputnik V coronavirus vaccine confirming its high eff... |
| Aug 25, 2021 | A new study in Argentina on Sputnik V: “Our observations suggest that protection increases over 6 months following vaccination as a consequence of antibody maturation, resulting in improved potency of antibodies to viral escape mutations.” | Moscow, August 25, 2021 – The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) announces results of a study in Argentina with authors noting that protection against coronavirus increases over 6 months following vaccinat... |
| Aug 25, 2021 | Indonesia becomes the 70th country to authorize Sputnik V | Total population of all countries where Sputnik V is approved for use now exceeds 4 billion people, which is more than half of the global population. |
| Aug 23, 2021 | The single-component Sputnik Light vaccine authorized in Philippines | Moscow, August 23, 2021 – The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) today announced the Russian single-component Sputnik Light vaccine against coronavirus has been approved under the emergency use authorizati... |
| Aug 20, 2021 | A combination between AstraZeneca and the first component of Sputnik V vaccine (Sputnik Light) demonstrates high immunogenicity profile in the clinical study in Azerbaijan | Moscow, August 20, 2021 – The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund), AstraZeneca and R-Pharm announce preliminary results on immunogenicity of combined use of the AstraZeneca vaccine (developed jointly with t... |
| Aug 18, 2021 | Real-world data shows one shot Sputnik Light vaccine (the first component of the Sputnik V vaccine) has high safety and 93.5% efficacy against COVID during vaccination in Paraguay | Moscow, August 18, 2021 – The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) announces the data from Paraguay’s Ministry of Health on the one shot Russian Sputnik Light vaccine (the first component of the Sputnik V va... |
| Aug 12, 2021 | Laboratorios Richmond delivers the first batch of over 1 million doses of the Sputnik V vaccine produced in Argentina to the country’s Ministry of Health | Laboratorios Richmond has delivered 995,125 doses of the first component of Sputnik V to the Ministry of Health of Argentina. The Company has also supplied 152,500 doses of the second component of the vaccine out of 3 million doses to be pr... |
| Aug 11, 2021 | The Russian Direct Investment Fund: on the first anniversary of Sputnik V registration official data from leading countries confirms the vaccine’s high safety and efficacy profile | Moscow, August 11, 2021 – The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund), investor in the Russian Sputnik V vaccine against coronavirus, announces the results of its joint work with Ministries of Health and regula... |
| Aug 4, 2021 | Combination of the first component of Sputnik V vaccine (Sputnik Light vaccine) with vaccines by AstraZeneca, Sinopharm and Moderna demonstrates high safety profile during the study in Argentina’s Buenos-Aires province | Moscow, August 4, 2021 – The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) announces the initial safety results of the randomized, single-blind study for the evaluation of the immune response and safety of heterogene... |
| Aug 3, 2021 | Laboratorios Richmond to provide Argentina with over 3 million doses of the second component of the Sputnik V vaccine in August with the first 150,000 doses to become available for vaccination this week | Moscow, August 3, 2021 – The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) and Argentina’s Laboratorios Richmond SACIF pharmaceutical company today announced the Sputnik V vaccine produced at Company’s facilities wil... |
| Jul 31, 2021 | First batches of the Sputnik V vaccine produced in Uzbekistan by Jurabek Laboratories | Moscow, July 31, 2021 – The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund), and one of the leading pharmaceutical companies of Uzbekistan, Jurabek Laboratories, today announced the first batches of the Russian Sputnik... |
| Jul 30, 2021 | The world’s first study of a combination between the AstraZeneca vaccine and the first component of the Sputnik V vaccine (Sputnik Light) in Azerbaijan shows no serious adverse events or COVID infection cases following the vaccination | Moscow, July 30, 2021 – The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) announces initial safety results of the world’s first study of a combination between the AstraZeneca vaccine (developed jointly with the Unive... |
| Jul 21, 2021 | Sputnik V approved for use in Chile | Moscow, July 21, 2021 – The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) announces the approval of the Russian Sputnik V vaccine against coronavirus in the Republic of Chile. |
| Jul 21, 2021 | First batch of the Sputnik V vaccine produced in Vietnam | Moscow, July 21, 2021 – The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund), and VABIOTECH, one of Vietnam’s leading pharmaceutical companies, announce the production of a test batch of the Russian Sputnik V vaccine ag... |
| Jul 15, 2021 | Sputnik V vaccine against coronavirus authorized in Nigeria | Moscow, July 15, 2021 – The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) announces the approval of the Russian Sputnik V vaccine against coronavirus by the National Agency for Food and Drug Administration and Contro... |
| Jul 15, 2021 | Single-dose Sputnik Light vaccine registered in Kazakhstan | Moscow, July 15, 2021 – The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) announces the approval of the Russian single-dose Sputnik Light vaccine against coronavirus by the Ministry of Health of Kazakhstan. |
| Jul 13, 2021 | RDIF and Serum Institute of India, the world’s largest vaccine manufacturer by volume, to start production of Sputnik vaccine at Company’s facilities in September | Moscow, July 13, 2021 – The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund), and Serum Institute of India (SII), the world’s largest vaccine manufacturer by volume, today announced cooperation to produce the Russian Sp... |
| Jul 12, 2021 | Sputnik V vaccine elicits high IGG antibodies and neutralizing antibodies titers, a study in Argentina published in international Cell Reports Medicine journal shows | Moscow, July 12, 2021 – The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund), investor in the Russian Sputnik V vaccine against coronavirus, today announced results of a study in Argentina on vaccine’s IgG anti-spike ti... |
| Jul 12, 2021 | Sputnik V vaccine effective against new variants of coronavirus, the Gamaleya Center study published in Vaccines leading international journal, shows | Moscow, July 12, 2021 – The Gamaleya National Research Center of Epidemiology and Microbiology and the Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) today announced strong results of the study on neutralizing activit... |
| Jul 11, 2021 | Sputnik V vaccine demonstrates strong safety profile during vaccination campaign in San Marino | Moscow, July 11, 2021 – The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund), investor in the Russian Sputnik V vaccine against coronavirus, today announced positive safety data of the vaccine in San-Marino obtained dur... |
| Jul 6, 2021 | RDIF and Morepen Laboratories announce production of the test batch of Sputnik V in India | Moscow, July 6, 2021 – The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund), and Morepen Laboratories, one of the leading manufacturers of pharmaceutical products in India, today announced the production of the test bat... |
| Jul 5, 2021 | Test batch of the Sputnik V vaccine produced in Mexico | Moscow, July 5, 2021 – The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) and Mexican pharmaceutical company Laboratorios de Biológicos y Reactivos de México (BIRMEX) announce the production of a test batch of the Rus... |
| Jun 30, 2021 | Joint venture between RDIF and Fortum invests in wind power plants in Kalmykia with a capacity of 200 MW | Moscow, June 30, 2021 – The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) and Fortum, a leading Nordic energy company and the leading renewable energy company in Russia, announce the investments in acquisition of Sal... |
| Jun 29, 2021 | Sputnik V has demonstrated 97.8% efficacy against COVID cases and 100% efficacy against severe cases of COVID in UAE | Moscow, June 29, 2021 – The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) announces the data of UAE’s Ministry of Health on the Russian Sputnik V coronavirus vaccine confirming its safety and high efficacy during the... |
| Jun 26, 2021 | Test batch of the Sputnik V vaccine produced in Iran | Moscow, June 26, 2021 – The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund), and Actoverco, one of Iran’s leading pharmaceutical companies, announce the production of a test batch of the Russian Sputnik V vaccine again... |
| Jun 25, 2021 | Single-dose Sputnik Light vaccine registered in Kyrgyzstan | Moscow, June 25, 2021 – The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) announces the approval of the Russian single-dose Sputnik Light vaccine against coronavirus by the Ministry of Health of the Kyrgyz Republic.... |
| Jun 11, 2021 | Single-dose Sputnik Light vaccine registered in Mongolia | Moscow, June 11, 2021 – The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) announces the approval of the Russian single-dose Sputnik Light vaccine against coronavirus by the Ministry of Health of Mongolia. |
| Jun 10, 2021 | Sputnik V demonstrates 94.3% efficacy and high safety profile during the vaccination campaign in Bahrain | Moscow, June 10, 2021 – The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) announces the data of the Ministry of Health of the Kingdom of Bahrain on the Russian Sputnik V coronavirus vaccine confirming its safety and ... |
| Jun 7, 2021 | Single-dose Sputnik Light vaccine approved for use in the Republic of the Congo | Moscow, June 7, 2021 – The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) announces the approval of the Russian single-dose Sputnik Light vaccine against coronavirus by the Ministry of Health of the Republic of the Co... |
| Jun 5, 2021 | Brazil becomes the 67th country in the world to authorize Sputnik V vaccine | Brazil is the most populated country of South America where Sputnik V is approved for use |
| Jun 4, 2021 | RDIF and Sanofi to develop digital healthcare solutions in Russia | Saint-Petersburg, June 4, 2021 – The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) and Sanofi, one of the leading global pharmaceutical companies, agree to cooperate for joint implementation of digital healthcare pro... |
| Jun 4, 2021 | RDIF and Belgium’s La Lorraine Bakery Group announce joint investments in Russian food production industry | Saint-Petersburg, June 4, 2021 – The Russian Direct Investment Fund (RDIF), Russia’s sovereign wealth fund, and Belgium’s La Lorraine Bakery Group (LLBG), one of the leading producers in Europe of bakery products, announce a cooperation agr... |
| Jun 4, 2021 | RCIF and SberInvest to invest RUB1.6 bn in Eruditor Group | Eruditor Group owns Profi and Zoon services |
| Jun 3, 2021 | RDIF, Mumtalakat and Binnopharm Group to establish production of the Russian Sputnik V coronavirus vaccine in Bahrain | Saint-Petersburg, June 3, 2021 – The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund), Bahrain’s Mumtalakat Holding Company (Mumtalakat, sovereign wealth fund of the Kingdom of Bahrain) and Binnopharm Group (а subsidiar... |
| Jun 3, 2021 | RDIF and Ruskhim Group to cooperate on creation of a new vertically integrated gas chemical complex in the Russian Arctic | Saint-Petersburg, June 3, 2021 – The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) and Ruskhim Group announce a partnership providing for the Fund’s investment in Company's project to create a new vertically integrat... |
| Jun 2, 2021 | Single-dose Sputnik Light vaccine approved for use in Mauritius | Moscow, June 2, 2021 – The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) announces the approval of the Russian single-dose Sputnik Light vaccine against coronavirus by the Ministry of Health and Wellness of the Repub... |
| Jun 2, 2021 | Sputnik Light vaccine (the first component of Sputnik V vaccine) demonstrates 78.6-83.7% efficacy among the elderly in Argentina | Moscow, June 2, 2021 – The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) announces that the Russian Sputnik Light coronavirus vaccine (the first component of Sputnik V vaccine) demonstrates 78.6-83.7% efficacy among ... |
| May 31, 2021 | Single-dose Sputnik Light vaccine approved for use in Palestine | Moscow, May 31, 2021 – The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) announces the approval of the Russian single-dose Sputnik Light vaccine against coronavirus by the Ministry of Health of the State of Palestine... |
| May 28, 2021 | Sputnik V demonstrates highest safety profile during the vaccination campaign in Serbia | Moscow, May 28, 2021 – The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) announces that the latest official vaccination data in Serbia confirms Sputnik V Russian coronavirus vaccine to be the safest among COVID vacci... |
| May 27, 2021 | RDIF and UNICEF sign Sputnik V vaccine supply agreement | Moscow, May 27, 2021 – Human Vaccine LLC, a wholly owned subsidiary of the Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) announces the signing of an agreement for the supply of 220 million doses of two-dose Sputnik V... |
| May 25, 2021 | RDIF and partners invest $250 mn in IVI, Russia’s leading online video streaming service | Moscow, May 25, 2021 – A consortium of investors, including the Russian Direct Investment Fund (RDIF, Russia's sovereign wealth fund), VTB Capital, Invest AG, Millhouse, leading sovereign funds of the Middle East, Baring Vostok and Flashpoi... |
| May 24, 2021 | A study in Argentina confirms Sputnik V highly-effective against Manaus variant of coronavirus | Moscow, May 24, 2021 – The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) announces that a study carried out by Argentina’s Institute of Virology of the National University of Cordoba and the Government of Cordoba has... |
| May 24, 2021 | RDIF and Panacea Biotec launch the production of Sputnik V in India | Moscow, May 24, 2021 – The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) and Panacea Biotec, one of the leading vaccine and pharmaceutical producers in India, today announced the launch of production of the Russian S... |
| May 20, 2021 | Single-dose Sputnik Light vaccine approved for use in Nicaragua | Moscow, May 20, 2021 – The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) announces the approval of the Russian single-dose Sputnik Light vaccine against coronavirus by the Ministry of Health of the Republic of Nicara... |
| May 15, 2021 | Single-dose Sputnik Light vaccine approved for use in Venezuela | Moscow, May 15, 2021 – The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) announces the approval of the Russian single-dose Sputnik Light vaccine against coronavirus by the Ministry of Health of the Bolivarian Republi... |
| May 15, 2021 | Sputnik V approved for use in the Republic of Ecuador | Moscow, May 15, 2021 – The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) announces the approval of the Russian Sputnik V vaccine against coronavirus in the Republic of Ecuador. |
| May 14, 2021 | Vaccination with Sputnik V launched in India | Sputnik V has become the first foreign-made vaccine used in India |
| May 13, 2021 | Sputnik V approved for use in the Republic of Maldives | Maldives became the 65th country in the world to register the Russian vaccine |
| May 12, 2021 | Sputnik Light vaccine approved for use in Angola | Moscow, May 12, 2021 – The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) announces the approval of the Russian single-dose Sputnik Light vaccine against coronavirus by the Ministry of Health of the Republic of Angola... |
| May 10, 2021 | The Sputnik V vaccine helps San Marino to become the first country in Europe to defeat COVID and reduce the infection rate to zero | The Sputnik V vaccine helps San Marino to become the first country in Europe to defeat COVID and reduce the infection rate to zero |
| May 6, 2021 | Single dose vaccine, Sputnik Light, authorized for use in Russia | Sputnik Light is the first component (recombinant human adenovirus serotype number 26 (rAd26)) of Sputnik V – the world’s first registered vaccine against coronavirus. |
| Apr 30, 2021 | Sputnik V approved for use in Albania | Moscow, April 30, 2021 – The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) announces the approval of the Russian Sputnik V vaccine against coronavirus by the Ministry of Health and Social Protection of the Republic o... |
| Apr 30, 2021 | Turkey becomes the 63rd country in the world to authorize Sputnik V | Moscow, April 30, 2021 – The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) announces that the Ministry of Health of the Republic of Turkey has registered the Russian Sputnik V vaccine against coronavirus in the count... |
| Apr 29, 2021 | RDIF, KIDF and Mubadala announce the signing of Memorandum of Understanding | Moscow, April 29, 2021 – Within the framework of the Eurasian Intergovernmental Council in Kazan (Russian Federation), a Memorandum of Understanding was signed on April 28, 2021 between the Russian Direct Investment Fund (RDIF), “Kazakhstan... |
| Apr 27, 2021 | Sputnik V authorized in Bangladesh | Moscow, April 27, 2021 – The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) announces that the Directorate general of Drug Administration (DGDA) under the Ministry of Health & Family Welfare of the People's Republ... |
| Apr 26, 2021 | RDIF and Viscoran İlaç agree to produce the Sputnik V vaccine in Turkey | Moscow, April 26, 2021 – The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund), and Turkey’s Viscoran İlaç pharmaceutical company have agreed to cooperate on production of the world’s first registered vaccine against cor... |
| Apr 22, 2021 | RDIF and Minapharm agree to produce over 40 million doses of the Sputnik V vaccine in Egypt | Moscow/Cairo/Berlin, April 22, 2021 – The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund), Egypt’s Minapharm, the regional leader in recombinant DNA technology, and its Berlin-based subsidiary ProBioGen AG announce the... |
| Apr 20, 2021 | Production of Sputnik V launched in Argentina | Moscow, April 20, 2021 – The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) and Laboratorios Richmond SACIF pharmaceutical company today announced the production of the first batch of the Russian Sputnik V vaccine aga... |
| Apr 19, 2021 | RDIF and ER-Telecom invest in the creation of the leading Russian cloud service based on Linxdatacenter assets | Moscow, April 19, 2021 – The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) alongside JSC ER-Telecom Holding (Dom.ru and Dom.ru Business trademarks) and Talos Fund I LP, the leading fund from the Middle East specializ... |
| Apr 19, 2021 | RDIF and Hualan Biological Bacterin agree to produce over 100 million doses of the Sputnik V vaccine in China | Moscow, April 19, 2021 – The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund), and Hualan Biological Bacterin Inc. (a subsidiary company of one of China’s leading biopharmaceutical producers and the largest influenza va... |
| Apr 19, 2021 | Sputnik V demonstrates 97.6% efficacy according to analysis of data from 3.8 million vaccinated persons in Russia making it the most efficient COVID-19 vaccine in the world | Moscow, April 19, 2021 – The Gamaleya National Research Center of Epidemiology and Microbiology of the Ministry of Health of the Russian Federation and the Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) today announce... |
| Apr 15, 2021 | RDIF, GL Rapha and ISU ABXIS to cooperate for production of Sputnik V in Korea | Moscow, April 15, 2021 – The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund), GL Rapha, one of the leading South Korean bio-tech companies, and ISU ABXIS (a subsidiary of ISU GROUP) have signed an agreement for technol... |
| Apr 14, 2021 | Production of Sputnik V launched in Serbia | Moscow, April 14, 2021 – The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) and Institute of Virology, Vaccines and Sera “Torlak” announce the launch of production of the Russian Sputnik V vaccine against coronavirus ... |
| Apr 12, 2021 | Sputnik V vaccine authorized in India | India has become the 60th country to approve Sputnik V |
| Apr 9, 2021 | RDIF and partners invest in Russian personal care goods producer ZetTek | Moscow, April 9, 2021 – The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund), Mubadala Investment Company (Mubadala), an Abu Dhabi-based global sovereign investor, and other partners today announce an investment in Russ... |
| Apr 8, 2021 | RVC and Sber to launch a $100 mn fund for investment in tech startups | Moscow, April 8, 2021 – Russian Venture Company (RVC, part of the Russian Direct Investment Fund, Russia’s sovereign wealth fund) and Sber have announced their intention to launch a $100 mn joint fund for investment in technological and sci... |
